Cell migration is one of the many processes orchestrated by calcium (Ca 2+ ) signaling, and its dysregulation drives the increased invasive and metastatic potential of cancer cells. The ability of Ca 2+ to function effectively as a regulator of migration requires the generation of temporally complex signals within spatially restricted microdomains. The generation and maintenance of these Ca 2+ signals require a specific structural architecture and tightly regulated communication between the extracellular space, intracellular organelles, and cytoplasmic compartments. New insights into how Ca 2+ microdomains are shaped by interorganellar Ca 2+ communication have shed light on how Ca 2+ coordinates cell migration by directing cellular polarization and the rearrangement of structural proteins. Importantly, we are beginning to understand how cancer subverts normal migration through the activity of oncogenes and tumor suppressors that impinge directly on the physiological function or expression levels of Ca 2+ signaling proteins. In this review, we present and discuss research at the forefront of interorganellar Ca 2+ signaling as it relates to cell migration, metastasis, and cancer progression, with special focus on endoplasmic reticulum-to-mitochondrial Ca 2+ transfer.
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2+
) signaling (1). Cancer is no exception, with many primary tumor cells and cell lines displaying aberrant expression of Ca 2+ signaling genes (2, 3). While it is unlikely that somatic mutations affecting any one individual Ca 2+ signaling gene are sufficient to drive tumorigenesis (4, 5), remodeling of the Ca
signal in cancer appears almost universal and confers survival advantages (3, 6). And so, it may be that dysfunctional Ca 2+ signaling is indeed a determinant of tumorigenesis when coincident with cancer-driving oncogene and tumor suppressor mutations.
Also, many oncoproteins and tumor suppressor proteins can themselves directly modulate Ca 2+ signaling. They achieve this, in large part, by interacting with Ca 2+ channels, pumps, and exchangers localized at the plasma membrane and various intracellular compartments. The Bcl-2 family of oncoproteins has been the most extensively studied in this respect and found to regulate Ca 2+ signaling in ways that complement their roles as apoptotic regulators, as recently reviewed (7). Similarly, oncogenic Ras (8, 9) and the tumor suppressors promyelocytic leukemia (PML) (10), p53 (11), and BRCA1 (12) can all regulate apoptosis by impinging on the Ca 2+ signal. Many of these proteins are enriched in spatially restricted domains created by the close apposition between the endoplasmic reticulum (ER) and the mitochondria, known as mitochondria-associated membranes (MAMs), where they function to modulate the flow of Ca 2+ from the ER to mitochondria. Ca 2+ signaling also plays a role in cancer cell invasion and metastasis. Several different plasma membrane and ER-localized Ca 2+ channels regulate the activity of effectors involved in motility and adhesion. Most of this regulation occurs by modifying the cytoplasmic Ca 2+ signal and has been reviewed previously (13, 14). The significance of ER-mitochondrial Ca 2+ communication in invasion and metastasis, however, has only recently emerged. This review will assess the literature relating to ER-mitochondrial Ca 2+ communication. Our goal is to outline a theoretical framework that mechanistically links cancer-driven changes in ER-mitochondrial Ca 2+ communication to its invasive and metastatic properties. We have made every attempt to include and reference original studies specifically related to this topic. When discussing a well-established concept, however, we direct readers to an appropriate review article.
Ca

2+ SiGnALinG ReGULATeS MULTiPLe STePS OF THe invASiOn-MeTASTATiC CASCADe
Tumor metastasis directly accounts for the vast majority of cancer deaths (15). Metastasis is characterized by a sequence of events known as the invasion-metastatic cascade (16, 17). During this process, cancer cells lose their attachment to other cells and the extracellular matrix (ECM), acquire migratory capabilities and invade neighboring tissues by degrading and moving through the ECM, and ultimately transit to secondary sites by finding their way into the blood and lymphatic circulation. Importantly, Ca 2+ signaling plays a key role at a number of points in the invasionmetastatic cascade.
Adhesion and epithelial-Mesenchymal Transition (eMT)
The invasion-metastatic cascade begins with the loss of cell-ECM and cell-cell adhesion. Cells are linked to the ECM at focal adhesion points by structural complexes connecting membrane spanning integrins to the cytoskeleton. And so, the rate of focal adhesion assembly and disassembly governs the cell's migratory ability. The process of disassembly is Ca 2+ sensitive and triggered by Ca 2+ oscillations that promote the association of focal adhesion kinase (FAK), a regulator of focal adhesion turnover, with the focal adhesion complex (18). The Ca 2+ oscillations, which are spatially restricted at the focal adhesions (19), increase the residency of FAK at these sites through Ca 2+ /calmodulin-dependent protein kinase II (CaMKII)-dependent regulation of its phosphorylation status (19) (20) (21) (22) .
The loss of cell-cell adhesion is also mediated through the process of EMT (23). The EMT process converts polarized epithelial cells into highly motile mesenchymal cells, defined by the induction of the mesenchymal markers N-cadherin, vimentin, and transcription factors, Snail, Slug, and Twist. Induction of EMT in the MDA-MB-231 breast cancer cell line was dependent on increased store-operated Ca2 + entry (SOCE) driven by expression of the SOCE proteins, stromal interaction molecule 1 (STIM1) and Orai1 (24) 2+ influx determines how these enzymes influence metastasis. In a prostate cancer cell study, the metastatic potential was dependent on the expression of MMP2, MMP9, and cathepsin B regulated by Ca 2+ influx through the transient receptor potential melastatin 2 (TRPV2) channel (42). Another study identified a role for SOCE (43). Activation of STIM/Orai was shown to influence melanoma metastasis by maintaining levels of membrane type1 MMP (MT1-MMP) at the plasma membrane (43). signal and affect the invasion-metastatic cascade by impinging on the cytoplasmically localized effectors outlined above (22, 45). As alluded to earlier, cancer is also associated with altered mitochondrial Ca 2+ handling, brought about by changes in the expression profile of the mitochondrial Ca 2+ uptake machinery, as well as oncoproteins and tumor suppressors at the MAM (46). Recent investigations using primary tumor models and cancer cell lines support the concept that the survival advantages of altered mitochondrial Ca 2+ derive from effects on cellular metabolism (47) and apoptosis sensitivity (48-52). In the following section, we assess the evidence that altered ER-mitochondrial Ca 2+ is also a determinant of increased invasive and metastatic potential (Figure 1 ).
Mitochondria-Associated Membrane
The ER-localized inositol 1,4,5-trisphosphate receptor (IP3R) and ryanodine receptor Ca 2+ release channels deliver Ca 2+ to the mitochondria (53-55). Structural elements, which include physical tethers linking both membranes (56, 57) and protein-protein interactions that bridge the ER release and mitochondrial uptake machinery (58, 59), facilitate the Ca 2+ transfer. To get to the matrix, Ca 2+ first moves across the outer mitochondrial membrane through the voltage-dependent anion channel (VDAC) (60) (61) (62) . The VDAC is a porin channel and diffusion pathway for ions and metabolites (62) . Despite its large pore size, VDAC can function as a highly regulated Ca 2+ permeability (63, 64) that directly couples to IP3R-dependent Ca 2+ release through interactions with the mitochondrial chaperone GRP75 (58). From the intermembrane space, Ca 2+ moves across the inner membrane through the mitochondrial Ca 2+ uniporter (MCU) (65, 66) . Cancer remodels the MAM architecture by changing the expression levels of ER and mitochondrial Ca 2+ channel proteins or their associated binding partners and regulators (46). Restructuring the MAMs and the resultant effects on mitochondrial Ca 2+ homeostasis impinges on many processes including metabolism, bioenergetics, cell death, proliferation, mitochondrial dynamics, and cytoplasmic Ca 2+ signaling. For the purpose of this review, we restrict our focus to those effects that most profoundly impact, or are likely to impact, invasion and metastasis.
voltage-Dependent Anion Channel
Expression of the VDAC1 isoform is robustly increased in many cancer cell types (67) and reliably predicts survival outcomes in breast, colon, and lung cancers (68, 69) . Increased VDAC likely promotes cancer cell growth primarily by influencing mitochondrial metabolism and apoptosis (70) (71) (72) , processes that are also tightly regulated by VDAC interactions with hexokinase and members of the Bcl-2 family (72) (73) (74) . Importantly, VDAC1 knockdown reduced cancer cell migration in vitro and suppressed tumor growth in vivo (75, 76) . A decrease in VDAC expression would be expected to limit mitochondrial Ca 2+ uptake (61). Indeed, VDAC influences cell migration by a mechanism that involves the regulation of mitochondrial Ca 2+ uptake by interactions with Bcl-2 family proteins. The structural determinants and functional correlates of the VDAC-Bcl-2 protein interactions have been well characterized, as reviewed in Ref. 67 . Antiapoptotic Bcl-XL and MCL1 both bind to VDAC1 and VDAC3 isoforms to promote mitochondrial Ca 2+ uptake and drive cell migration (77) (78) (79) (80) . Importantly, disrupting the Bcl-XL-VDAC and MCL1-VDAC interactions was found to inhibit migration of triple negative breast cancer cells (80) and non-small cell lung carcinoma cells, respectively (78) . These data raise the possibility of suppressing invasion and metastasis by targeting VDAC-Bcl-2 protein interactions.
inositol 1,4,5-Trisphosphate Receptors
The type 3 IP3R isoform (IP3R-3), which is absent in normal colorectal mucosa, is expressed in colorectal carcinoma. Moreover, the expression is greatest at the invasive margin and strongly correlated with metastasis and patient survival (81) . The IP3R-3 is also overexpressed in human glioblastoma tissue (82) . Inhibiting IP3Rs in glioblastoma cell lines reduced invasion in vitro; it also reduced invasion in vivo and prolonged survival by suppressing tumor growth (82) . These studies, however, did not define the mechanisms by which increased IP3R-3 expression directs invasion and metastasis. Interestingly, the IP3R-3 is enriched in at the MAM in some cell types (83) , and it may preferentially deliver Ca 2+ to the mitochondria under certain conditions (84) . It is possible then that increased IP3R abundance promotes invasion and metastasis by increasing Ca 2+ delivery to the mitochondria.
Mitochondrial Ca 2+ Uniporter
The MCU machinery includes the MCU pore-forming subunit (65, 66) 
Mitochondrial Dynamics
Mitochondria redistribute to the leading edge of cancer cells to support the increased bioenergetic demands at the invadopodia (102) (103) (104) (105) . Interestingly, the translocation of mitochondria to subplasmalemmal sites also plays a critical role during immune cell activation, where they regulate Ca 2+ influx through SOCE (106) . It is yet to be determined, however, if mitochondrial positioning, and its influence on Ca 2+ influx, affects the polarization of cytoplasmic Ca 2+ signaling in migrating cancer cells. The translocation of mitochondria is dependent on increased mitochondrial fission, a process also promoted by mitochondrial Ca 2+ accumulation (107, 108) . Evidence that MCU plays a role in fission comes from the observation that fission is inhibited by the pharmacological block of the MCU (109, 110) and enhanced by loss-of-function mutations in MICU1, which promote mitochondrial Ca 2+ uptake (111) . Mechanistically, mitochondrial Ca 2+ might influence fission by regulating the activity of dynamin-related protein 1 (Drp1). The ability of Drp1 to promote fission is dependent on phosphorylation at serine 616 (S616) and dephosphorylation of serine 637 (S637) (112, 113) . Cytoplasmic Ca 2+ signaling is known to regulate the phosphorylation status of Drp1 through calcineurin-dependent dephosphorylation of S637 (112, 114) , and more recently it was found that blocking the MCU suppressed fission by decreasing Drp1 phosphorylation at S616 (115) . These observations are relevant to this review because Drp1 is widely associated with tumor invasion and metastatic potential (104, (116) (117) (118) , and increased S616 is found in breast cancer and lymph node metastases (104) . Although speculative, it is possible that increased mitochondrial Ca 2+ uptake in cancer cells links to invasion and metastasis through the processes of fission and mitochondrial localization.
Bioenergetics
Mitochondrial Ca 2+ activates several Ca
2+
-dependent enzymes involved in the tricarboxylic acid (TCA) cycle (119) . Work by Cárdenas et al. showed that constitutive low-level ER-mitochondrial Ca 2+ transfer maintains flux through the TCA cycle to fuel oxidative phosphorylation and ATP production (120) . In a follow-up study, the same group showed that blocking IP3Rs in cancer cells impaired oxidative phosphorylation, which killed cells by necrosis and reduced tumor growth in vivo (47). Although not examined in these studies, one might expect a similarly invoked bioenergetic crisis to inhibit cancer cell invasion and metastasis. Such an outcome is predicated based on the requirement for functional oxidative phosphorylation in tumor metastasis (121, 122) , as well as the spatially restricted bioenergetic demands needed for cell migration (102) (103) (104) (105) .
Reactive Oxygen Species (ROS)
Mitochondrial ROS are generated as a consequence of normal respiration. As electrons supplied by the TCA cycle are passed down the electron transport chain, they escape, mostly at complex I and III, to react with O2 and produce ROS. Mitochondrial Ca 2+ uptake can increase ROS production at complexes I, III and IV under a variety of conditions. Although the mechanisms are still unclear, a number of possibilities have been proposed, as reviewed previously (123, 124) . Also, mitochondrial Ca 2+ can promote the release of ROS accumulated in cristae and intermembrane spaces through Ca 2+ -dependent increases in matrix volume (125) .
Increased mitochondrial ROS production is a known determinant of tumor growth and metastasis (126, 127) that likely drives invasion and metastasis by increasing cell migration (128) (129) (130) . Importantly, increased migration is repeatedly correlated with increased ER-mitochondrial Ca 2+ uptake (92) (93) (94) (95) . While excessive ROS production is toxic and excessive mitochondrial Ca 2+ uptake inhibits rather than promotes migration (78, 131) , physiological Ca 2+ -dependent ROS production is a major mitochondrially derived signal involved in regulating downstream effectors. In one study, increased ER-mitochondrial Ca 2+ transfer in non-small cell lung carcinoma cells was caused by MCL1-VDAC interactions that promoted cell migration by increasing mitochondrial ROS production (78) . In another study, increased mitochondrial Ca 2+ uptake increased breast cancer cell xenograft growth and metastasis by increased ROS-dependent expression of HIF-1α (92) . To our knowledge, HIF-1α is the only cell migration regulator that has been specifically linked to mitochondrial Ca 2+ -dependent ROS production. Nevertheless, many migration effectors are sensitive to ROS signaling (132 (92) . In addition, therapeutics originally designed to promote cell death might also be useful for limiting metastasis. In this case, the Bcl-2 inhibitors, both BH3 and BH4 mimetics (80, 133) , as well as recently developed MCL1 inhibitors (134) , would be expected to suppress cell migration by limiting ER-mitochondrial Ca 2+ transfer.
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